Drug/chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy and macular edema is a condition resulting from the use of certain medications or chemicals that lead to diabetes. This condition is clinically significant as it can result in vision impairment and requires careful monitoring and management. The ICD-10 Code E09.331 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this complication.
ICD-10 Code E09.331 represents drug or chemical-induced diabetes mellitus characterized by moderate nonproliferative diabetic retinopathy with macular edema. This code should be used when documenting cases where diabetes is a direct result of medication or chemical exposure, and the patient exhibits signs of diabetic retinopathy and macular edema, which necessitates appropriate clinical management and billing.
Drug/chemical-induced diabetes with moderate nonproliferative diabetic retinopathy and macular edema arises from the adverse effects of certain medications or chemicals that disrupt glucose metabolism. This condition can progress to significant visual impairment if not managed appropriately, highlighting the need for timely medical intervention.
ICD-10 Code E09.331 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to drug-induced diabetes and its ocular complications. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition.
In SOAP notes, ICD-10 Code E09.331 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of drug-induced diabetes with associated ocular complications. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Drug/chemical-induced diabetes with moderate nonproliferative diabetic retinopathy and macular edema requires a multifaceted approach to prevent complications and preserve vision.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E09.331 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 92014 | Ophthalmological examination, established patient. |
| 83036 | Hemoglobin A1c test for diabetes management. |
Common Questions About Using ICD-10 Code E09.331 for Drug/chem diab w moderate nonprlf diab rtnop w macular edema
What medications can cause drug-induced diabetes?
Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can lead to drug-induced diabetes by affecting insulin sensitivity or secretion.
How is diabetic retinopathy diagnosed?
Diabetic retinopathy is diagnosed through a comprehensive eye examination, including fundoscopic evaluation and imaging techniques like optical coherence tomography to assess retinal changes.
What are the treatment options for macular edema?
Treatment for macular edema may include intravitreal injections of anti-VEGF agents, corticosteroids, or laser therapy, depending on the severity and underlying cause.
How often should patients with drug-induced diabetes be monitored?
Patients with drug-induced diabetes should be monitored regularly, with blood glucose checks at least quarterly and annual ophthalmologic evaluations to assess for retinopathy.
Clinical Notes
SOAP notes
DAP notes
AI medical notes